Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals

Author:

Klementyeva O. E.1ORCID,Lunev A. S.1ORCID,Lunyova C. A.1ORCID

Affiliation:

1. State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Abstract

Radiopharmaceuticals differ from other medicines mainly by the specific nature of their pharmacological action based on radioactivity, by absence of multiple-dose regimens, and by miniscule concentrations of the active pharmaceutical ingredient (10-9–10-12 mol/L). However, the official regulations and standards do not contain specific requirements for preclinical evaluation of radiopharmaceuticals. The aim of the study was to summarise preclinical data on general toxicity of therapeutic radiopharmaceuticals, which were obtained by the Laboratory of Preclinical and Clinical Studies of Radiopharmaceuticals of the Federal State Budgetary Institution ‘State Research Center of the Russian Federation¾Burnasyan Federal Medical Biophysical Center’ of the Federal Medical Biological Agency. Results: the authors analysed criteria for: selection of the study design based on physico-chemical nature of the active pharmaceutical ingredient; calculation of doses and selection of dosage regimens for radiopharmaceuticals with different administration routes; radiation safety for personnel performing the study. The authors used the data on three therapeutic radiopharmaceuticals to formulate methodological approaches to preclinical evaluation of their general toxic properties. The analysis of long-term experience in preclinical studies of therapeutic radiopharmaceuticals demonstrated the need for a judicious individual approach to the development of a preclinical study design. The authors proposed methodological approaches to preclinical evaluation of general toxic properties of therapeutic radiopharmaceuticals, which make it possible to adequately assess potential toxic effects and obtain meaningful study results. Conclusions: there is a need for a specific guideline for preclinical studies of therapeutic radiopharmaceuticals, which would take into account specific pharmacological action and nuclear-physical characteristics of radionuclides.

Publisher

SCEEMP

Reference10 articles.

1. Guidelines for preclinical study of radiopharmaceuticals. Guidelines for experimental (preclinical) study of new pharmacological substances / under total. ed. R.U. Khabriev - 2nd ed., Revised. and add. - M .: JSC "Publishing House" Medicine ", 2005. - 832 p. (In Russ)

2. Guidelines for conducting preclinical studies of drugs. Part one / ed. A.N. Mironov. - M .: Grif i K, 2012 .-- 944 p. (In Russ)

3. Good practice for introducing radiopharmaceuticals for clinical use / International Atomic Energy Agency IAEA-TECDOC. – no. 1782. Vienna: IAEA, 2016. – 84 p. ISBN 978–92–0–111215–6

4. Sandeep S. Radiopharmaceuticals Regulations on Bioavailability and Bioequivalence: Present Status and Future Requirements / S. Sandeep, B. Ashish, K.S. Rakesh Mod Appl Bioequiv Availab. – 2017; 1(4): 555567. DOI: 10.19080/MABB.2017.01.555567.

5. Voloznev L.V., Klementyeva O.E., Korsunsky V.N., Lysenko N.P. Preclinical toxicity assessment of the radiopharmaceutical 188Re-zoledronic acid. Veterinary Medicine, 2013 (1-2): 45-47. (In Russ)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3